Strategic Consultation & Discovery Planning
Structured, multi-disciplinary approach to turn a therapeutic target into a viable clinical candidate through target validation and customized roadmap planning.
Explore capabilityConnect antibody discovery, linker-payload chemistry, conjugation, and validation in an integrated ADC research program.
The science
We offer comprehensive antibody-drug conjugate (ADC) services, including antibody discovery, linker-payload design and synthesis, and ADC conjugation, as well as in-vitro and in-vivo validation studies.
How we can help
Explore the services and methods available for your project.
Structured, multi-disciplinary approach to turn a therapeutic target into a viable clinical candidate through target validation and customized roadmap planning.
Explore capabilityIdentifying disease-associated molecules (proteins, receptors) and selecting high-affinity antibodies through in-vivo/in-vitro screening.
Explore capabilityIterative phases combining antibody engineering, linker chemistry, and cytotoxic payload selection to refine ADC structure for efficacy and safety.
Explore capabilityEarly-stage preclinical assessments validating candidate antibody binding affinity, target specificity, functional efficacy, and stability.
Explore capabilityTransitioning candidates from initial binding screens to functional development via in-vitro bioassays and in-vivo tumor xenograft studies.
Explore capabilityOptimizing lead antibodies through affinity maturation, humanization, and Fc engineering, and scaling up conjugation processes.
Explore capabilityEnsuring compliance with FDA guidelines from target validation to IND submission, including QTPP, mAb characterization, and CMC compliance.
Explore capabilityExplore in detail
Open a section to explore our full service scope and instrumentation.
Let’s work together
Talk with our scientific team about your requirements,
technical feasibility, and timelines.